School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

RxSight, Inc. RXST

Healthcare · Medical Devices

$4.81last close 2026-10-09 · market cap $200.06M · delayed data

Trailing returns

1M-24.01%
3M-5.31%
6M-28.95%
1Y-40.69%

Basis: Adjusted daily closes.

What it does

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery.

Open RXST in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies